Shubham Singh

Shubham Singh

Director DIN 07849129
DIN 07849129 First appointment Jul 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Jul 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Shubham Singh

Data last updated:

Shubham Singh was a Director at Medificial Healthtech Services Private Limited (from 2020) and Director at Affluence Healthcare Private Limited (from 2017).

DIN 07849129
First Appointment 05 Jul 2017
Oldest Company Age 9 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Mar 20202020Strike Off
Affluence Healthcare Private Limited U85200RJ2017PTC058493
Director05 Jul 20172017₹88,791 (FY 2019)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medificial Healthtech Services Private Limited
Affluence Healthcare Private Limited
Premium access

Shareholding and investment profile for Shubham Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shubham Singh

Shubham Singh was first appointed on 05 Jul 2017 as Director at Affluence Healthcare Private Limited. The most recent appointment on record is 28 Mar 2020 at Medificial Healthtech Services Private Limited.

Shubham Singh held 2 earlier board appointments: Medificial Healthtech Services Private Limited (Director, from 28 Mar 2020); Affluence Healthcare Private Limited (Director, from 05 Jul 2017).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available